| European Case Law Identifier: | ECLI:EP:BA:2011:R001210.20111214 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 14 December 2011 | ||||||||
| Case number: | R 0012/10 | ||||||||
| Petition for review of: | T 0232/08 | ||||||||
| Application number: | 98911246.1 | ||||||||
| IPC class: | A61K 38/16 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | B | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid | ||||||||
| Applicant name: | LG Life Sciences, Ltd. | ||||||||
| Opponent name: | Quadrant Drug Delivery Limited | ||||||||
| Board: | EBA | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: | |||||||||
| Keywords: | Inconsistency in the decision (no) Petition for review as far as not rejected as clearly inadmissible, rejected as clearly not allowable |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/r100012eu1.html
Date retrieved: 17 May 2021